MRNA250117C56000
- 0.11
- 0.000.00%
Moderna Newsroom
Moderna (MRNA) Stock Sinks As Market Gains: Here's Why
Moderna Options Spot-On: On January 14th, 93,043 Contracts Were Traded, With 789.01K Open Interest
On January 14th ET, $Moderna(MRNA.US)$ had active options trading, with a total trading volume of 93,043 options for the day, of which put options accounted for 54.6% of the total transactions, and
JP Morgan 2025: Moderna Stock Suffers After CEO Reveals Conservative 2025 Guidance
Unusual Options Activity: MDB, PCG and Others Attract Market Bets, MDB V/OI Ratio Reaches 95.2
EST Jan 14th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Moderna Stock Plummets 17% on 2025 Sales Guidance Slash
Why Moderna, EIX, CEG, and ANF Stock Dropped
J.P. Morgan Downgrades Moderna(MRNA.US) to Sell Rating
Daily short sale tracking: Maplebear's short volume increased by 9 million, with a short sale ratio of 38%
Maplebear(CART.US) ranked top of the list had the largest change in short volume (9.35 million shares), and the short volume ratio of Royal Bank of Canada(RY.US) reached 72.4%. See more about the top 10 list of short selling volume changes in the latest trading day of the US stock market.
5 Things to Know Before the Stock Market Opens Tuesday
Stocks Gain Pre-Bell Ahead of Latest PPI Report; Asia, Europe Strong
U.S. stock market opportunities | News of huge mergers brings Bullish sentiment! ITCI soared 34% overnight, and several Medical stocks surged on the news; Oil & Gas prices rose together! The Oil & Gas Sector collectively went up.
A multi-million dollar deal has been signed! The Israeli Ministry of Defense and the defense company Elbit Systems have had a strong start to the year, with overnight stock prices rising nearly 3%, setting new records.
Here's Why Moderna, Inc. (MRNA) Is Among Monday's Top Losers
Express News | Moderna : Leerink Partners Cuts Target Price to $27 From $31
The pandemic benefits have completely faded! Moderna (MRNA.US) has lowered its sales forecast for 2025 by 1 billion dollars.
Moderna (MRNA.US) has lowered its sales expectations for 2025 by about 1 billion dollars due to some unfavorable factors that may arise later this year.
S&P 500 Gains and Losses Today: Moderna Plunges After Big Cut to Sales Forecast
BofA Securities Maintains Moderna(MRNA.US) With Sell Rating, Maintains Target Price $41
Moderna Options Spot-On: On January 13th, 239.46K Contracts Were Traded, With 756.28K Open Interest
On January 13th ET, $Moderna(MRNA.US)$ had active options trading, with a total trading volume of 239.46K options for the day, of which put options accounted for 44.47% of the total transactions,
These Stocks Are Moving the Most Today: Micron, Intra-Cellular Therapies, and More -- Barrons.com
Sector Update: Health Care Stocks Rise Late Afternoon
Earnings Outlooks Hit Retailers, Moderna -- Market Talk